Skip to main content
. 2015 Jun 3;10(6):e0127057. doi: 10.1371/journal.pone.0127057

Fig 5. Immunotherapy using PS-liposomes filled with insulin peptides decreases T1D incidence.

Fig 5

Cumulative incidence (percentage) of T1D in NOD mice treated with PSAB-liposomes (PSAB-lipo, circles, n = 12), PS-liposomes (PS-lipo, squares, n = 18), and sham group (triangles, n = 26). Significant differences were found when compared group treated with PSAB-liposomes versus sham group (*p≤0.05, Kaplan-Meier log-rank analysis).